$65million fundraise for Savannah Energy plc
17th January 2022
Panmure Gordon is delighted to have acted as Joint Broker and Joint Bookrunner to Savannah Energy plc on its oversubscribed US$65 million…
Read more17th January 2022
Panmure Gordon is delighted to have acted as Joint Broker and Joint Bookrunner to Savannah Energy plc on its oversubscribed US$65 million…
Read more13th January 2022
Panmure Gordon is delighted to announce that it has been appointed as Sole Broker to REA Holdings (RE.L) on Wednesday 12th January…
Read more3rd December 2021
Panmure Gordon is delighted to have acted as Joint Broker and Joint Bookrunner to Urban Logistics REIT plc on its significantly oversubscribed £250m Issue.
Read more30th November 2021
Panmure Gordon is delighted to have acted as Nomad, Joint Broker and Bookrunner on the oversubscribed £25m placing of sustainable fuels technology company, Velocys…
Read more25th November 2021
Panmure Gordon is delighted to have acted as Nomad and Joint Bookrunner on the £350 million AIM IPO of Life Science REIT plc. It…
Read more2nd September 2021
Jeremy Cohen joins Panmure Gordon as Senior Advisor Panmure Gordon is pleased to announce the appointment of Jeremy Cohen as a Senior Advisor to…
Read more5th August 2021
Panmure Gordon are pleased to announce our appointment as Joint Broker to AEX Gold, an AIM and TSX-V listed independent mining corporation. The Company…
Read more4th August 2021
Value & Indexed Property Income Trust is a listed investment trust, investing in directly held UK commercial property and equities and is managed by…
Read more30th July 2021
HydrogenOne Capital Growth is the first London listed fund dedicated to the clean hydrogen sector providing access to clean hydrogen through investment in a…
Read more14th July 2021
14/07/21 We are very pleased to have acted as Joint Broker and Joint Bookrunner to Urban Logistics for a successful £108million fundraise. Urban…
Read more30th June 2021
28/06/21 Sponsor and Joint Bookrunner for GMS successful fundraise
Read more4th June 2021
03/06/21 Global biopharmaceutical company Arecor Therapeutics plc is admitted to AIM with a £20m IPO
Read more